Cord blood transfusions could be safer for preemies
NCT ID NCT07502781
First seen Apr 02, 2026 · Last updated Jun 23, 2026 · Updated 12 times
Summary
This study compares transfusions using umbilical cord blood versus standard adult donor blood in extremely premature infants. About 176 babies born before 28 weeks will be randomly assigned to receive either type of blood if needed. The goal is to see if cord blood reduces the risk of serious complications like lung disease, eye problems, or death.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTREMELY PREMATURE INFANT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Clínic de Barcelona - Maternitat
Barcelona, 08028, Spain
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
umbilical cord blood red blood cells
What this could lead to
If it works, this could provide a safer and more effective transfusion option for extremely premature infants, reducing complications like lung and eye problems.
What could go wrong
This is a small pilot study, so results may not be conclusive. Cord blood may not always be available, and the benefits over standard blood are not yet proven.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.